Mangalam Drugs And Organics cash flow

Latest FY26

Cash from operations: ₹4.2cr−90.2% on FY25
Capital spending: ₹11.9cr−41.1% on FY25
Free cash flow: −₹7.7cr₹22.4 cr in FY25
Cash from financing: ₹5.7cr−₹21.7 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	18.2	16.6	0.0	11.0
	—	16.2	14.9	0.0	12.8
	—	−0.0	−0.0	0.0	−0.0
	—	0.0	−0.9	0.0	—
	—	−0.6	0.0	0.0	—
	—	−1.1	0.0	0.0	—
	—	36.0	−15.2	0.0	−20.4
	—	−1.2	−11.1	0.0	—
	—	0.0	0.3	0.0	—
	—	6.6	4.6	0.0	—
	—	1.7	0.0	0.0	—
	—	−22.3	25.0	0.0	42.5
	—	−3.1	0.1	0.0	—
	—	−1.4	−1.6	0.0	—
	—	7.4	5.5	0.0	—
	—	−2.7	0.0	0.0	—
	—	−0.7	−0.4	0.0	—
Cash from operating activities
	−42.3	−48.6	4.8	−11.1	—
	—	53.0	37.9	0.0	—
	—	4.5	42.7	−11.1	39.5
	—	0.3	0.1	0.0	—
	—	4.2	42.6	−11.1	39.5
Cash from investing activities
	—	11.9	20.2	0.0	27.9
	—	0.2	0.7	0.0	—
	—	0.0	0.0	0.0	—
	—	−11.7	−19.5	0.0	−22.2
Cash from financing activities
	—	0.0	−6.8	0.0	—
	—	−21.9	0.0	0.0	—
	—	16.2	14.9	0.0	12.8
	—	5.7	−21.7	0.0	−16.6
	—	−1.9	1.4	−11.1	—
	—	−1.9	1.4	−11.1	0.7
	—	—	—	−11.1	—
Reference items
	−9.0	−14.9	35.8	17.4	—
	−3.9%	−6.4%	11.3%	4.7%	—
	−7.7	−7.7	22.4	−11.1	11.6
	—	0.4	0.7	—	—
	−₹4.88	−₹4.88	₹14.15	−₹7.00	₹7.33
	—	−0.09×	6.34×	1.22×	—
	—	0.3	0.1	0.0	—
	—	16.2	14.9	—	12.8

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MANGALAM₹29.11

Mangalam Drugs And Organics Limited

· Pharma & Health

₹ CrorePeersBIOFILCHEM LASA VINEETLAB ORTINGLOBE KREBSBIO ALPA BALPHARMA NATCAPSUQMcap ₹46.1 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	11.0	0.0	16.6	18.2	—
+ Finance Costs	12.8	0.0	14.9	16.2	—
+ Dividend Income	-0.0	0.0	-0.0	-0.0	—
+ Fair Value (Gains) / Losses	—	0.0	-0.9	0.0	—
+ Other Non-cash Items	—	0.0	0.0	-0.6	—
+ Other Reconciling Items	—	0.0	0.0	-1.1	—
Changes in Working Capital
+ Inventories	-20.4	0.0	-15.2	36.0	—
+ Trade Receivables — Current	—	0.0	-11.1	-1.2	—
+ Other Financial Assets — Non-current	—	0.0	0.3	0.0	—
+ Other Current Assets	—	0.0	4.6	6.6	—
+ Other Non-current Assets	—	0.0	0.0	1.7	—
+ Trade Payables — Current	42.5	0.0	25.0	-22.3	—
+ Other Financial Liabilities — Current	—	0.0	0.1	-3.1	—
+ Other Financial Liabilities — Non-current	—	0.0	-1.6	-1.4	—
+ Other Current Liabilities	—	0.0	5.5	7.4	—
+ Other Non-current Liabilities	—	0.0	0.0	-2.7	—
+ Provisions — Current	—	0.0	-0.4	-0.7	—
Cash from Operating Activities
Profit Before Tax (per I/S)	—	-11.1	4.8	-48.6	-42.3
+ Total Adjustments (incl. Working Capital)	—	0.0	37.9	53.0	—
Cash from Operations (pre-tax)	39.5	-11.1	42.7	4.5	—
+ Income Taxes Paid	—	0.0	0.1	0.3	—
Cash from Operating Activities	39.5	-11.1	42.6	4.2	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	27.9	0.0	20.2	11.9	—
+ Disp of Fixed Assets	—	0.0	0.7	0.2	—
+ Dividends Received — Investing	—	0.0	0.0	0.0	—
Cash from Investing Activities	-22.2	0.0	-19.5	-11.7	—
Cash from Financing Activities
+ Proceeds from Borrowings	—	0.0	-6.8	0.0	—
+ Repayment of Borrowings	—	0.0	0.0	-21.9	—
+ Interest Paid	12.8	0.0	14.9	16.2	—
Cash from Financing Activities	-16.6	0.0	-21.7	5.7	—
Net Changes in Cash (pre-FX)	—	-11.1	1.4	-1.9	—
Net Changes in Cash	0.7	-11.1	1.4	-1.9	—
Closing Cash	—	-11.1	—	—	—
Reference Items
EBITDA	—	17.4	35.8	-14.9	-9.0
EBITDA Margin %	—	4.72	11.26	-6.42	-3.87
Free Cash Flow (CFO − Capex)	11.6	-11.1	22.4	-7.7	-7.7
Free Cash Flow to Equity	—	—	0.7	0.4	—
Free Cash Flow per Basic Share	7.33	-7.00	14.15	-4.88	-4.88
Cash Flow to Net Income	—	1.22	6.34	-0.09	—
Cash Paid for Taxes	—	0.0	0.1	0.3	—
Cash Paid for Interest	12.8	—	14.9	16.2	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.